Clinical Trial Update: A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating AMG 951 (rhApo2L/TRAIL) in previously untreated non-small cell lung cancer patients treated with chemotherapy with or withou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AMG 951 (rhApo2L/TRAIL)

Snippet

Sponsor: Amgen | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED